EPIRUS Biopharmaceuticals to Host Biosimilar Key Opinion Leader Meeting and Webcast on March 30
March 25, 2015 07:00 ET
|
EPIRUS Biopharmaceuticals, Inc.
BOSTON, March 25, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal...
EPIRUS Reports Fourth Quarter and Fiscal Year 2014 Financial Results
March 23, 2015 16:35 ET
|
EPIRUS Biopharmaceuticals, Inc.
BOSTON, March 23, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal...
EPIRUS to Report Fourth Quarter and Fiscal Year 2014 Financial Results on March 24, 2015
March 11, 2015 07:00 ET
|
EPIRUS Biopharmaceuticals, Inc.
BOSTON, March 11, 2015 (GLOBE NEWSWIRE) -- EPIRUS Biopharmaceuticals, Inc. (Nasdaq:EPRS), a Boston-based biopharmaceutical company focused on the global development of biosimilar monoclonal...